Any planned research project to be conducted in California that requires the use of a Schedule I or Schedule II Controlled Substance (NO Schedule III, IV, and V) as its main study drug, including comparison drug(s), should be submitted to the Research Advisory Panel of California for review and approval.
Research is categorized into 4 groups:
Group 1: Academic human research of Schedule I or Schedule II medications - See Application Forms
Group 2: Research into the treatment of controlled substance addiction or abuse utilizing ANY scheduled or non-scheduled medications by an academic institution or by a multi or single center clinical drug trial research sponsored by NIDA and by a pharmaceutical company/CRO : SAT Research - See Application Forms
Note: SAT Clinical Drug Trials - Do not complete an Application Form
Group 3: Non-human research with animal models OR in-vitro studies of Schedule I medications only - See Application Forms
Group 4: Multi or single center clinical drug trial research sponsored by a pharmaceutical company/CRO evaluating or comparing any Schedule I and II medications - see Clinical Drug Trials
Submission Requirements for each group: